Voyager Therapeutics, Inc.
AAV VARIANTS WITH ENHANCED TROPISM
Last updated:
Abstract:
The disclosure relates to compositions, methods, and processes for the preparation, use, and/or formulation of adeno-associated virus capsid proteins, wherein the capsid proteins comprise targeting peptide inserts for enhanced tropism to a target tissue.
Status:
Application
Type:
Utility
Filling date:
2 Aug 2019
Issue date:
9 Sep 2021